⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

July 1, 2024Journal of Thoracic DiseaseOpen Access

Preliminary experience of surgery after neoadjuvant immunotherapy combined with chemotherapy for stage-IIIB non-small cell lung cancer

Yizong Ding Xiaojing Zhao Petros Christopoulos Travis C. Geraci Yujie Fu

View Full Paper

Ask AI

Bookmark

Share

Ask about this paper

Answers are grounded in this paper and cite their sources.

Ask your own question…

Abstract

Previously, stage-IIIB non-small cell lung cancer (NSCLC) has been considered inoperable. In recent years, neoadjuvant immunotherapy has shown encouraging efficacy in the treatment of advanced stage NSCLC in several trials. However, the effectiveness and safety of neoadjuvant immunotherapy in treating stage-IIIB NSCLC are still unknown. Therefore, we conducted this retrospective study to examine the outcomes of surgery after neoadjuvant immunotherapy combined with chemotherapy for stage-IIIB NSCLC.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Ding et al. (2024) studied this question.

synapsesocial.com/papers/68e62396b6db6435875b654d https://doi.org/10.21037/jtd-24-908

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 10 related papers. Consider them for comparative context:

1A case report of cStage IIIB squamous cell lung carcinoma completely resected after downstaging with neoadjuvant therapy2024 · 2 citations
2Subsequent surgical treatment or maintenance immunotherapy in stage <scp>III</scp> lung cancer patients achieving a favorable response following neoadjuvant immunotherapy: A matched retrospective cohort study from the surgical perspective2024 · 6 citations
3Evidence for the evolving role of neoadjuvant and perioperative immunotherapy in resectable non-small cell lung cancerLate-Phase Clinical Trial · 2024 · 1 citations
4The efficacy analysis of neoadjuvant chemoimmunotherapy followed by surgery in stage III locally advanced non-small cell lung cancer: a systematic review and meta-analysis2025 · 4 citations
5Evaluating the efficacy of neoadjuvant immunotherapy combined with chemotherapy for stage IIIa non-small cell lung cancer2025
6Immunotherapy for resectable NSCLC: neoadjuvant/perioperative followed by surgery over surgery followed by adjuvant. Systematic review and meta-analysis with subgroup analyses2025 · 18 citations
7Clinical outcomes associated with neoadjuvant therapy for the treatment of resectable non‐small cell lung cancer in real‐world practice2024 · 6 citations
8317P A phase II clinical study of neoadjuvant immunogenic radiotherapy followed by ivonescimab (PD-1/VEGF-A bispecific antibody) and chemotherapy in stage II-III non-small cell lung cancerEarly-Phase Clinical Trial · 2026
9Machine learning predicts major adverse cardiovascular events following modified Morrow surgery for hypertrophic obstructive cardiomyopathyJournal of Thoracic Disease · 2026
10From risk factors to individualized prediction: development and internal validation of a machine learning model for early identification of postoperative pneumonia after lung cancer surgeryJournal of Thoracic Disease · 2026

More from Journal of Thoracic Disease

More from Heidelberg University

More from Shanghai Jiao Tong University

More from University Hospital Heidelberg

More from NYU Langone Health

More from German Center for Lung Research

More from Renji Hospital